Literature DB >> 33956758

Etiology of Infectious Diseases in Acutely Ill Children at a Pediatric Hospital in Finland.

Hilla Pöyry1,2, Anna Raappana1, Minttu Kiviniemi1, Tytti Pokka1,2, Minna Honkila1,2, Niko Paalanne1,2, Pekka Valmari3, Marjo Renko4, Terhi Tapiainen1,2,5.   

Abstract

This is a brief report of the etiology of infectious diseases in a pediatric emergency department. Our cohort study of 4647 children demonstrated rhinovirus as the most common etiology in a pediatric emergency department (23%) and intensive care (48%). The population-based incidence of rhinovirus-related visits was 1796/100,000/yr in children <5 years. The most common bacterial pathogen was Escherichia coli (5%).
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33956758      PMCID: PMC8104009          DOI: 10.1097/INF.0000000000003091

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


Infections represent the most common type of acute diseases in childhood. Vaccination programs have resulted in a reduction of infectious diseases in children.[1] After the introduction of the rotavirus vaccine and the pneumococcal conjugate vaccine, a substantial decrease in rates of gastroenteritis and pneumonia has been observed in many countries.[2,3] Yet, pediatric emergency departments (EDs) remain crowded.[4] In Finland, in hospitals with pediatric referral EDs, active microbiologic diagnostics are performed, which involve wide use of multiplex polymerase chain reaction for respiratory and enteric pathogens.[5] We aimed to demonstrate the current distribution of microbial etiology of all acute infections. We investigated the etiology of infections treated at a pediatric ED for one epidemiologic year in a cohort study of 4600 acutely ill children.

MATERIALS AND METHODS

Our study included 4647 consecutive pediatric ED patients provided with both secondary and tertiary cares at Oulu University Hospital, Finland. During the study period, nasal swabs were obtained from all patients with respiratory symptoms or fever of unknown origin. All infants, children and adolescents younger than 16 years old with respiratory symptoms or fever of unknown origin were investigated for viral etiology from September 2014 to August 2015 using multiplex polymerase chain reaction (Anyplex II RV16, Seegene, South Korea). Nasopharyngeal swab samples were frozen and analyzed with a bacterial respiratory panel in 2017–2018 (Allplex Respiratory Panel 4, Seegene). In 2019–2020, we reviewed all medical records, including serologic and microbiologic samples. We examined the risk for hospitalization or intensive care, depending on the children’s microbial etiology and diagnosis. The data were obtained from the electronic patient registration system. The National Supervisory Authority for Welfare and Health, Valvira (V/56413/2017), and the Ethics Committee of Oulu University Hospital, Finland, found the study protocol acceptable (32/2017). During the study, the influenza vaccine for children 6–35 months old and the rotavirus vaccine were included in the National Immunization Program. However, varicella and maternal pertussis immunizations were not part of the National Immunization Program during the study.

RESULTS

Among the 4647 children visiting the pediatric ED, infections were the main reason for the visit in 55% (n = 2559) of the patients. The mean age of the children was 4.6 years (SD = 4.8). Altogether, 29% of patients were infants and 16% were younger than 3 months old. The etiology was determined in 62% (n = 1582) of 2559 patients with a clinical infection diagnosis (Table 1), including 206 of 355 patients (58%) with upper respiratory tract infection diagnoses, 99/291 (34%) with gastroenteritis diagnoses, 164/287 (57%) with unspecified viral infection diagnoses, 153/246 (62%) with viral wheezing diagnoses, 113/234 (48%) with otitis media diagnoses, 81/178 (46%) with pneumonia diagnoses and 766/1582 (48%) with other clinical infection diagnoses. The most common clinical diagnoses in children without a specific known etiology (n = 977, 38%) were gastroenteritis (7.5%, n =192), upper respiratory tract infection (5.8%, n = 149), otitis media (4.7%, n = 121), pneumonia (3.8%, n = 97), viral wheezing (3.6%, n = 93), unspecified fever (1.8%, n = 45), acute croup (1.4%, n = 37) and febrile seizure (1.2%, n = 30).
TABLE 1.

Etiology of Infectious Diseases in Acutely Ill Children Visiting a Pediatric Emergency Department

EtiologyED Infection Visits (n = 2559)Infections Admitted to the Ward (n = 1527)Infections Admitted to PICU (n = 31)
n (%)95% CIn (%)95% CIn (%)95% CI
Rhinovirus581 (23)21–24194 (13)11–1415 (48)30–67
Adenovirus216 (8.4)7.4–9.685 (5.6)4.5–6.81 (3.2)0.1–17
RSV150 (5.5)5.0–6.889 (5.8)4.7–7.11 (3.2)0.1–17
Metapneumovirus141 (5.5)4.7–6.557 (3.7)2.8–4.82 (6.5)0.8–21
Bocavirus123 (4.8)4.0–5.763 (4.1)3.2–5.21 (3.2)0.1–17
Escherichia coli*115 (4.5)3.7–5.480 (5.2)4.2–6.50 (0)0–11
Parainfluenza 1-4111 (4.3)3.6–5.256 (3.7)2.8–4.73 (9.7)2.0–26
Coronaviruses107 (4.2)3.4–5.045 (2.9)2.2–3.90 (0)0–11
Influenza A51 (2.0)1.5–2.620 (1.3)0.8–2.00 (0)0–11
Influenza B51 (2.0)1.5–2.614 (0.9)0.5–1.51 (3.2)0.1–17
Enterovirus50 (2.0)1.5–2619 (1.2)0.8–1.91 (3.2)0.1–17
Staphylococcus aureus*50 (2.0)1.5–2633 (2.2)1.5–3.02 (6.5)0.8–21
Streptococcus pneumoniae*34 (1.3)0.9–1.926 (1.7)1.1–2.50 (0)0–11
Rotavirus28 (1.1)0.7–1.625 (1.6)1.1–2.40 (0)0–11
Norovirus25 (1.0)0.6–1.413 (0.9)0.5–1.50 (0)0–11
Streptococcus pyogenes*21 (0.8)0.5–1.213 (0.9)0.5–1.51 (3.2)0.1–17
VZV20 (0.8)0.5–1.210 (0.7)0.3–1.20 (0)0–11
Haemophilus influenzae*17 (0.7)0.4–1.111 (0.7)0.4–1.30 (0)0–11
Klebsiella spp.*15 (0.5)0.3–1.06 (0.4)0.1–0.90 (0)0–11
Francisella tularensis*14 (0.5)0.3–0.95 (0.3)0.1–0.80 (0)0–11
Herpes simplex9 (0.4)0.2–0.77 (0.5)0.2–0.90 (0)0–11
Mycoplasma pneumoniae*6 (0.2)0.1–0.52 (0.1)0.0–0.51 (3.2)0.1–17
EBV5 (0.2)0.1–0.53 (0.2)0.0–0.60 (0)0–11
Pseudomonas aeruginosa4 (0.1)0.0–0.44 (0.3)0.1–0.70 (0)0–11
Bordetella pertussis3 (0.1)0.0–0.32 (0.1)0.0–0.51 (3.2)0.1–17
Borrelia burgdorferi3 (0.1)0.0–0.33 (0.2)0.0–0.60 (0)0–11
Salmonella spp.2 (0.04)0.0–0.21 (0.1)0.0–0.41 (3.2)0.1–17
Streptococcus agalactiae2 (0.04)0.0–0.21 (0.1)0.0–0.41 (3.2)0.1–17
Chlamydia pneumoniae1 (0.04)0.0–0.20 (0)0.0–0.20 (0)0–11
Clostridium difficile1 (0.04)0.0–0.21 (0.1)0.0–0.40 (0)0–11
Campylobacter jejuni1 (0.04)0.0–0.21 (0.1)0.0–0.40 (0)0–11
CMV1 (0.04)0.0–0.21 (0.1)0.0–0.40 (0)0–11
Neisseria meningitidis0 (0)0.0–0.10 (0)0.0–0.20 (0)0–11
H. influenzae B0 (0)0.0–0.10 (0)0.0–0.20 (0)0–11
EHEC0 (0)0.0–0.10 (0)0.0–0.20 (0)0–11

E. coli: urine (n = 110), soft tissue (n = 5), blood (n = 1), CSF (n = 1), one patient had both meningitis and urosepsis; S. aureus: soft tissue (n = 48), blood (n = 2); S. pneumoniae: nasopharynx (n = 31) with clinical pneumococcal bacteremia or pneumonia, blood (n = 3); S. pyogenes: throat (n = 10), soft tissue (n = 7), blood (n = 1), conjunctiva (n = 1), scarlet fever (n = 2); H. influenzae: nasopharynx (n = 17) with clinical pneumonia; Klebsiella spp.: urine (n = 11), soft tissue (n = 4); F. tularensis (endemic in the region): serology (n = 5), typical clinical ulceroglandular presentation (n = 9) and M. pneumoniae: nasopharynx (n = 6), from patients with respiratory symptoms or fever.

229E, NL63, OC43.

Fecal samples rarely obtained from outpatients.

CMV indicates cytomegalovirus; CSF, cerebrospinal fluid; EBV, Epstein Barr virus; EHEC, enterohemorrhagic E. coli; PICU, pediatric intensive care unit; RSV, respiratory syncytial virus; VZV, varicella zoster virus.

Coinfections were not excluded and were common for bocavirus (60%) and rhinovirus (36%) infections. The sample sites of most common bacterial pathogens, marked with

, are presented under the table.

Etiology of Infectious Diseases in Acutely Ill Children Visiting a Pediatric Emergency Department E. coli: urine (n = 110), soft tissue (n = 5), blood (n = 1), CSF (n = 1), one patient had both meningitis and urosepsis; S. aureus: soft tissue (n = 48), blood (n = 2); S. pneumoniae: nasopharynx (n = 31) with clinical pneumococcal bacteremia or pneumonia, blood (n = 3); S. pyogenes: throat (n = 10), soft tissue (n = 7), blood (n = 1), conjunctiva (n = 1), scarlet fever (n = 2); H. influenzae: nasopharynx (n = 17) with clinical pneumonia; Klebsiella spp.: urine (n = 11), soft tissue (n = 4); F. tularensis (endemic in the region): serology (n = 5), typical clinical ulceroglandular presentation (n = 9) and M. pneumoniae: nasopharynx (n = 6), from patients with respiratory symptoms or fever. 229E, NL63, OC43. Fecal samples rarely obtained from outpatients. CMV indicates cytomegalovirus; CSF, cerebrospinal fluid; EBV, Epstein Barr virus; EHEC, enterohemorrhagic E. coli; PICU, pediatric intensive care unit; RSV, respiratory syncytial virus; VZV, varicella zoster virus. Coinfections were not excluded and were common for bocavirus (60%) and rhinovirus (36%) infections. The sample sites of most common bacterial pathogens, marked with , are presented under the table. Rhinovirus was the most common pathogen in all age groups, found in 23% (n = 581) of children with an infection. Other respiratory viruses were detected frequently; the viruses occurring most often with other viruses were bocavirus (60%) and rhinovirus (36%). The most common bacterial pathogen among the 2559 infections was Escherichia coli, detected in 4.5% (n = 115) of the patients (Table 1). Their diagnoses were pyelonephritis or urinary tract infection (95%), abscess (4.3%) and, in one case, meningitis with sepsis (0.1%). Mycoplasma pneumoniae was found in 0.2% (n = 6) of the patients. We detected only two Streptococcus agalactiae infections and no meningococcal infections. The annual population-based incidence of rhinovirus infections leading to a pediatric ED visit was 849/100,000 [95% confidence interval (CI), 791–910] for children under 16 years old and 1796/100,000 (95% CI, 1643–1959) for children under 5 years old. The annual incidence of E. coli infections was 210/100,000 (95% CI, 182–241) for children under 16 years old and 281/100,000 (95% CI, 222–351) for children under 5 years old. Among the 31 patients with infections admitted to the pediatric intensive care unit, rhinovirus was the most common pathogen, detected in 15 patients (48%) (Table 1). Nine of these patients had severe respiratory symptoms, mainly wheezing, with rhinovirus as the sole pathogen. One child had a prolonged febrile seizure, and rhinovirus was the sole pathogen. Severe bacterial infections were rare; only nine patients had sepsis (0.4% of patients with infections), caused by Streptococcus pneumoniae (n = 3), Staphylococcus aureus (n = 2), S. agalactiae (n = 2), E. coli (n = 1) and Streptococcus pyogenes (n = 1). Vaccine-preventable diseases were diagnosed in 150 of 2559 patients with an infection (5.9%), including influenza in 102 (4.0 %), rotavirus in 28 (1.1%) and varicella in 20 (0.8%) patients (Table 1). Pertussis caused the only death, which occurred in an unvaccinated young infant.

DISCUSSION

Our study demonstrated that rhinovirus was the most common etiology of infectious diseases in acutely ill children at a pediatric referral ED (23%) and in intensive care (48%). Population-based incidence of rhinovirus-related ED visits was high. In adults, rhinovirus has been reported to be an important pathogen in intensive care.[6] In children, rhinovirus has been reported to cause the majority of asthma exacerbations and wheezing episodes.[7] The most common bacterial etiology of acute infectious diseases was E. coli (5%), which is consistent with previous studies showing a high occurrence of febrile urinary tract infections in infants and young children.[8] In the present study, the possible or probable etiology of infections was detected in most of the acutely ill children at a referral clinic. Respiratory viruses caused more than 60% of infections with confirmed etiology. During the study period, the occurrence of respiratory syncytial virus was low. Based on the Finnish registry data, the number of respiratory syncytial virus infections might be 2- to 3-fold greater in epidemic years.[9] The occurrence of influenza was not lower than average. Notably, this study was conducted before the coronavirus disease 2019 pandemic. In this study, rhinovirus was associated with severe morbidity and intensive care treatment in children. The main limitation of the present study was that the detection of a prevalent respiratory pathogen, such as rhinovirus, by molecular methods does not directly confirm causality between respiratory symptoms and the pathogen. Thus, because of the observational study design, not all the respiratory findings can be interpreted as the confirmed cause of the infection. Based on the present study, the effective prevention and treatment of rhinovirus infections, other respiratory viral infections and E. coli infections would markedly reduce the burden of pediatric ED visits and hospitalizations in a high-income country with a comprehensive immunization program.
  9 in total

1.  The role of rhinovirus in asthma exacerbations.

Authors:  Samuel L Friedlander; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2005-08       Impact factor: 10.793

2.  Change in respiratory syncytial virus seasonality in Finland.

Authors:  Marjo Renko; Terhi Tapiainen
Journal:  Acta Paediatr       Date:  2019-09-16       Impact factor: 2.299

3.  The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.

Authors:  H Peltola; O P Heinonen; M Valle; M Paunio; M Virtanen; V Karanko; K Cantell
Journal:  N Engl J Med       Date:  1994-11-24       Impact factor: 91.245

4.  Prevalence of urinary tract infection in childhood: a meta-analysis.

Authors:  Nader Shaikh; Natalia E Morone; James E Bost; Max H Farrell
Journal:  Pediatr Infect Dis J       Date:  2008-04       Impact factor: 2.129

5.  Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study.

Authors:  Arto A Palmu; Hanna Rinta-Kokko; Hanna Nohynek; J Pekka Nuorti; Terhi M Kilpi; Jukka Jokinen
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

6.  Viral etiology of common cold in children, Finland.

Authors:  Aino Ruohola; Matti Waris; Tobias Allander; Thedi Ziegler; Terho Heikkinen; Olli Ruuskanen
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

7.  Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia.

Authors:  J Karhu; T I Ala-Kokko; T Vuorinen; P Ohtonen; H Syrjälä
Journal:  Clin Infect Dis       Date:  2014-04-11       Impact factor: 9.079

8.  Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15.

Authors:  Brian Wahl; Katherine L O'Brien; Adena Greenbaum; Anwesha Majumder; Li Liu; Yue Chu; Ivana Lukšić; Harish Nair; David A McAllister; Harry Campbell; Igor Rudan; Robert Black; Maria Deloria Knoll
Journal:  Lancet Glob Health       Date:  2018-07       Impact factor: 26.763

9.  Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland.

Authors:  Maria Hemming; Sirpa Räsänen; Leena Huhti; Minna Paloniemi; Marjo Salminen; Timo Vesikari
Journal:  Eur J Pediatr       Date:  2013-01-30       Impact factor: 3.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.